Matthew Reed
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$4.0MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $4.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Dec 20, 2024 | NIH | SBIR Phase II Aerosolized Epigenetic Therapy for Metastatic Lung Cancer | $1.1M | Nob Hill Therapeutics, Inc. |
| Sep 19, 2023 | NIH | SBIR Phase II Aerosolized Epigenetic Therapy for Metastatic Lung Cancer | $861K | Nob Hill Therapeutics, Inc. |
| Jun 19, 2023 | NIH | SBIR Phase II Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections | $564K | Nob Hill Therapeutics, Inc. |
| Jun 28, 2022 | NIH | SBIR Phase II Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections | $1.2M | Nob Hill Therapeutics, Inc. |
| Feb 15, 2020 | NIH | SBIR Phase I Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections | $299K | Nob Hill Therapeutics, Inc. |
Peer ranks
Federal funding#388
Awards as PI#417
Patents#273
Companies
- Nob Hill Therapeutics, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.